We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
TGO 91 and TGO 92 are registered on the Federal Register of Legislation and a guidance document is available to assist you in complying with the requirements.
These Orders came into effect on 31 August 2016, which started a four year transition period.
The transition period ended on 31 August 2020. All affected medicines released for supply from 1 September 2020 must comply with the labelling requirements of TGO 91 or 92.
Leftover stock in warehouses can still be supplied as long as it was released before 1 September 2020. This stock should be minimal as the four year transition period has allowed time for sponsors to update labels and release existing stock.
There is also a standard for biologicals - TGO 107: Standard for Biologicals - Labelling Requirements.